Download video

Breast Cancer: The Latest Target for Immunotherapy, with Leisha Emens

5.3K views

Cancer Research Institute

10 years ago

Breast Cancer: The Latest Target for Immunotherapy, with Leisha Emens

Breast Cancer: The Latest Target for Immunotherapy, with Leisha Emens

Breast Cancer: The Latest Target for Immunotherapy, with Leisha Emens
45:09
Breast Cancer: The Latest Target for Immunotherapy, with Leisha Emens
by Cancer Research Institute
Breast Cancer and Immunotherapy with Dr. Leisha Emens and Barbara Bigelow
33:31
Breast Cancer and Immunotherapy with Dr. Leisha Emens and Barbara Bigelow
by Cancer Research Institute
TNBC: immunotherapy in the neoadjuvant setting
3:37
TNBC: immunotherapy in the neoadjuvant setting
by OncoInfoTV
Mini-organs reveal new target for breast cancer immunotherapy
3:04
Mini-organs reveal new target for breast cancer immunotherapy
by AJE Video Bytes
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer
5:25
Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer
by ecancer
Research into New Immunotherapies for Breast Cancer
0:50
Research into New Immunotherapies for Breast Cancer
by Stanford Health Care
New Ways Immunotherapy Targets Breast Cancer, with Silvia Formenti
46:33
New Ways Immunotherapy Targets Breast Cancer, with Silvia Formenti
by Cancer Research Institute
IMMUNOTHERAPY: The Path to a Cancer Cure (For Clinicians)
8:42
IMMUNOTHERAPY: The Path to a Cancer Cure (For Clinicians)
by Society for Immunotherapy of Cancer
Immunotherapy: Boosting the immune system to fight cancer
7:32
Immunotherapy: Boosting the immune system to fight cancer
by nature video
Today Immunotherapy can cure even fourth stage cancer: Dr Dattatreyudu Nori
8:46
Today Immunotherapy can cure even fourth stage cancer: Dr Dattatreyudu Nori
by ETHealthWorld
Why Immune Cell Expression in Breast Cancer is Important
0:42
Why Immune Cell Expression in Breast Cancer is Important
by OncLive
Immunotherapy and targeted treatments in breast cancer reviewed
6:21
Immunotherapy and targeted treatments in breast cancer reviewed
by ecancer
IMpassion130 and IMpassion131: The difference a taxane makes? | Leisha Emens
2:20
IMpassion130 and IMpassion131: The difference a taxane makes? | Leisha Emens
by Medicine Matters oncology
Monitor Toxicities When Treating Breast Cancer With Immunotherapy
0:51
Monitor Toxicities When Treating Breast Cancer With Immunotherapy
by OncLive
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
5:59
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
by ecancer
Successes and challenges in designing combination immunotherapy clinical trials for breast cancer
5:46
Successes and challenges in designing combination immunotherapy clinical trials for breast cancer
by ecancer
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in ad...
1:57
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in ad...
by ecancer
Dr. Emens on Immune-Related Adverse Events in Ovarian Cancer
1:12
Dr. Emens on Immune-Related Adverse Events in Ovarian Cancer
by OncLive
Future role of immunotherapy in HER2+ breast cancer
0:34
Future role of immunotherapy in HER2+ breast cancer
by VJOncology
Women’s Cancers: A Speed Science Panel
1:03:00
Women’s Cancers: A Speed Science Panel
by Stanford Medicine
Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West Oncology
2:10
Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West Oncology
by Total Health | Oncology
Immunotherapy for Inflammatory Breast Cancer | 2023 Inflammatory Breast Cancer Program Patient Forum
18:22
Immunotherapy for Inflammatory Breast Cancer | 2023 Inflammatory Breast Cancer Program Patient Forum
by Dana-Farber Cancer Institute
Breast Cancer Breakout: Rapid research developments and new treatment combinations
33:26
Breast Cancer Breakout: Rapid research developments and new treatment combinations
by Cancer Research Institute